2001, ISBN: 9789048157785
[ED: Taschenbuch], [PU: Springer Netherlands], Neuware - The fifth meeting in the successful series Helicobacter pylori: Basic Mechanisms to Clinical Cure took place in Maui, Hawaii, Nove… Meer...
booklooker.de |
2002, ISBN: 9789048157785
The fifth meeting in the successful series Helicobacter pylori: Basic Mechanisms to Clinical Cure took place in Maui, Hawaii, November 2002. The meeting focused on all current aspects of … Meer...
BetterWorldBooks.com Verzendingskosten:zzgl. Versandkosten., exclusief verzendingskosten Details... |
2001, ISBN: 9789048157785
[ED: Taschenbuch], [PU: Springer Netherlands], Neuware - H. pylori infection, both in man and in the laboratory animal, has become a standard model to investigate fundamental problems in … Meer...
booklooker.de |
Helicobactor pylori | Basic Mechanisms to Clinical Cure 2002 | G. N. Tytgat (u. a.) | Taschenbuch | Paperback | XXII | Englisch | 2010 | Springer Netherland | EAN 9789048157785 - pocketboek
2010, ISBN: 9789048157785
gebonden uitgave
[ED: Taschenbuch], [PU: Springer Netherland], H. pylori infection, both in man and in the laboratory animal, has become a standard model to investigate fundamental problems in biology, su… Meer...
booklooker.de |
2010, ISBN: 9048157781
gebonden uitgave
Softcover reprint of hardcover 1st ed. 2003 Kartoniert / Broschiert Krankheiten und Störungen, Gastrointestinale und kolorektale Chirurgie, gastritis; Antibiotics; Antigen; bacteria; Ca… Meer...
Achtung-Buecher.de MARZIES.de Buch- und Medienhandel, 14621 Schönwalde-Glien Verzendingskosten:Sans frais d'envoi en Allemagne. (EUR 0.00) Details... |
2001, ISBN: 9789048157785
[ED: Taschenbuch], [PU: Springer Netherlands], Neuware - The fifth meeting in the successful series Helicobacter pylori: Basic Mechanisms to Clinical Cure took place in Maui, Hawaii, Nove… Meer...
Hunt, R. H. / Tytgat, G. N.:
Helicobacter Pylori: Basic Mechanisms to Clinical Cure 2002 - gebruikt boek2002, ISBN: 9789048157785
The fifth meeting in the successful series Helicobacter pylori: Basic Mechanisms to Clinical Cure took place in Maui, Hawaii, November 2002. The meeting focused on all current aspects of … Meer...
2001
ISBN: 9789048157785
[ED: Taschenbuch], [PU: Springer Netherlands], Neuware - H. pylori infection, both in man and in the laboratory animal, has become a standard model to investigate fundamental problems in … Meer...
Helicobactor pylori | Basic Mechanisms to Clinical Cure 2002 | G. N. Tytgat (u. a.) | Taschenbuch | Paperback | XXII | Englisch | 2010 | Springer Netherland | EAN 9789048157785 - pocketboek
2010, ISBN: 9789048157785
gebonden uitgave
[ED: Taschenbuch], [PU: Springer Netherland], H. pylori infection, both in man and in the laboratory animal, has become a standard model to investigate fundamental problems in biology, su… Meer...
2010, ISBN: 9048157781
gebonden uitgave
Softcover reprint of hardcover 1st ed. 2003 Kartoniert / Broschiert Krankheiten und Störungen, Gastrointestinale und kolorektale Chirurgie, gastritis; Antibiotics; Antigen; bacteria; Ca… Meer...
Bibliografische gegevens van het best passende boek
auteur: | |
Titel: | |
ISBN: |
Gedetalleerde informatie over het boek. - Helicobacter pylori: Basic Mechanisms to Clinical Cure 2002: Basic Mechanisms to Clinical Cure 2002 The proceedings of a symposium organised by AXCAN PHARMA, held in Maui, Hawaii, November 10-13, 2002
EAN (ISBN-13): 9789048157785
ISBN (ISBN-10): 9048157781
Gebonden uitgave
pocket book
Verschijningsjaar: 2010
Uitgever: Springer-Verlag GmbH
560 Bladzijden
Gewicht: 0,836 kg
Taal: eng/Englisch
Boek bevindt zich in het datenbestand sinds 2011-05-16T16:46:23+02:00 (Amsterdam)
Detailpagina laatst gewijzigd op 2023-12-17T10:55:11+01:00 (Amsterdam)
ISBN/EAN: 9789048157785
ISBN - alternatieve schrijfwijzen:
90-481-5778-1, 978-90-481-5778-5
alternatieve schrijfwijzen en verwante zoekwoorden:
Auteur van het boek: tytgat, hunt
Titel van het boek: helicobacter pylori, helico
Gegevens van de uitgever
Auteur: R.H. Hunt; G.N. Tytgat
Titel: Helicobactor pylori - Basic Mechanisms to Clinical Cure 2002
Uitgeverij: Springer; Springer Netherland
538 Bladzijden
Verschijningsjaar: 2010-12-01
Dordrecht; NL
Gedrukt / Gemaakt in
Gewicht: 0,854 kg
Taal: Engels
213,99 € (DE)
219,99 € (AT)
236,00 CHF (CH)
POD
XXII, 538 p.
BC; Gastroenterology; Hardcover, Softcover / Medizin/Klinische Fächer; Gastrointestinale und kolorektale Chirurgie; Verstehen; Gastritis; antibiotics; antigen; bacteria; cancer; carcinogenesis; cell; gastric cancer; helicobacter pylori; infection; liver; lymphoma; pathogenesis; stomach; infectious diseases; Infectious Diseases; Oncology; Gastroenterology; Diseases; Oncology; Krankheiten und Störungen; Onkologie; BB
Section I: The New Helicobacters.- 1 What are the new helicobacters?.- 2 Helicobacter hepaticus and Helicobacter bilis: proinflammatory modulators of enterohepatic disease.- 3 Epidemiology and postulated pathogenesis of liver and biliary tract pathogenic Helicobacter species.- 4 Evidence implicating Helicobacter spp. in the pathogenesis of inflammatory bowel disease.- Section II: Strain Differences of Helicobacter pylori.- 5 The hierarchy of markers of virulence and disease causation — useful or disappointing?.- 6 SHP-2 tyrosine phosphatase and the Helicobacter pylori virulence factor CagA.- 7 What is the exact role of Lewis antigens and autoantibodies in Helicobacter pylori-related disease?.- 8 Putative role of Helicobacter antigen in functional dyspepsia: a conceptual model.- 9 Acid adaptation of Helicobacter pylori.- 10 Co-migration of Helicobacter pylori and humans: the evolving story.- Section III: Helicobacter pylori and Gastritis — The Ongoing Saga.- 11 Progress in our understanding of H. pylori infection and gastritis.- 12 The role of pepsinogen assays as surrogate markers of gastritis dynamics in population studies.- 13 Multifocal Atrophic Gastritis (MAG) does not exist: new finding based on sectioning the entire stomach.- 14 Multifocal Atrophic Gastritis (MAG) is real, and important.- 15 Are there reliable non-invasive approaches to assessing gastritis for epidemiologic studies?.- 16 Animal models of gastritis: Helicobacter pylori and high-salt diet in the gerbil.- Section IV: Helicobacter pylori and Gastric Malignancy.- 17 The evolving epidemiology of Helicobacter pylori infection and gastric cancer.- 18 Virulence of Helicobacter pylori infection and gastric cancer: lessons from mouse models.- 19 The role of bacterial overgrowth in the stomach as an additional risk factor for gastritis.- 20 Role of ascorbate in gastric juice and the impact of Helicobacter pylori infection.- 21 Mechanisms of injury: the effects of Helicobacter pylori on cell cycle control.- 22 Role of interleukin-1 beta and other potential genetic markers as indicators of gastric cancer risk.- 23 Results of intervention trials in Helicobacter pylori-infected populations.- 24 Which lessons can be drawn from the study of Helicobacter pylori related MALT lymphoma?.- Section V: Helicobacter pylori and Clinical Issues.- 25 Helicobacter pylori eradication leads to gastro-oesophageal reflux disease.- 26 Helicobacter pylori eradication does not lead to gastro-oesophageal reflux disease.- 27 Helicobacter pylori eradication in non-ulcer dyspepsia: the case for.- 28 Helicobacter pylori eradication does not benefit non-ulcer dyspepsia.- 29 Helicobacter pylori and dyspepsia strategies — debate: Yes — A test-and-treat strategy is a viable option in primary care.- 30 A ‘test-and-treat’ strategy is obsolete in primary care.- 31 Helicobacter pylori should be eradicated in patients receiving long-term acid suppression.- 32 Helicobacter pylori eradication is not necessary before longterm proton pump inhibitor treatment.- 33 Helicobacter pylori and non-steroidal anti-inflammatory drugs: the debate is over.- Section VI: Ongoing Clinical Issues with Helicobacter pylori Infection.- 34 What are the global response rates to Helicobacter pylori eradication therapy?.- 35 What is the Helicobacter pylori global reinfection rate?.- 36 Is it time for quadruple therapy to be first line?.- 37 Eradication therapy should be different for dyspeptic patients compared with ulcer patients.- 38 Helicobacter pylori resistance to antibiotics: prevalence, mechanism, detection. What’s new?.- 39 Antibiotic sensitivities of Helicobacter pylori vary at different gastric mucosal sites.- 40 Can the response to eradication therapy in Helicobacter pylori infection be predicted?.- 41 What constitutes failure of H. pylori eradication therapy?.- 42 How can the current strategies for eradication therapy be improved?.- 43 Novel targets for Helicobacter pylori eradication.- 44 Helicobacter pylori management: how to improve the therapeutic confusion in practice.- 45 Ethical issues in the management of Helicobacter pylori infection.- 46 Are there geographic/regional differences in Helicobacter pylori eradication?.- Section VII: Global Consensus Update.- 47 Management of Helicobacter pylori infection — a review of the available regional and national guidelines.- 48 Asia Pacific guidelines for the management of Helicobacter pylori infection.- 49 What is the impact of the regional guidelines? China.- 50 H. pylori infection: Clinical management from a European perspective.- 51 What is the impact of the regional guidelines? South America.- 52 Guidelines for management of Helicobacter pylori infection in the Middle East.- 53 Global consensus update for managing Helicobacter pylori infection: critical issues from the United States.- 54 Guidelines in the management of Helicobacter pylori infection in Japan.- 55 A proposal for future Helicobacter pylori eradication guidelines.- Section VIII: Priorities for Future Research.- 56 Priorities for future research: microbiology.- 57 Priorities for further research in Helicobacter pylori management — the way forward.Andere boeken die eventueel grote overeenkomsten met dit boek kunnen hebben:
Laatste soortgelijke boek:
9780792387176 Helicobacter pylori by R.H. Hunt Hardcover | Indigo Chapters (Hunt, R. H. Tytgat, Guido N. J.)
< naar Archief...